IP Library › Granted Patent US 10,494,671
Granted Patent B2
US 10,494,671 · App. 13/980,280 · Granted Dec 3, 2019

Enzymatic ligation of nucleic acids

Inventors: Stephen Hendricks (Los Gatos, CA); David King (San Francisco, CA)
Assignee: LIFE TECHNOLOGIES CORPORATION
C12Q1/6874A61J1/062A61J1/14B65B3/003B65B3/006B65B31/046B65D15/02C12N9/93C12Q1/6876A61J2200/76A61J2205/30A61M5/008A61M5/5086B65B55/08B65B55/10C12Q2600/16C12Y605/01001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,494,671
App. No.
13/980,280
Granted
Dec 3, 2019
Kind
B2
Abstract

Methods, assays, compositions and kits for the ligation of short polynucleotides are presented herein. The short polynucleotides are optionally no more than 7 nucleotides in length, and can be as short as 3 or 4 nucleotides in length. The ligation is optionally performed by CV ligase.

Claims (27)

1. A method of template-dependent ligation, said method comprising:

a. enzymatically ligating a proximal terminus of a first oligonucleotide and a proximal terminus of a second oligonucleotide, wherein the proximal termini of the first and the second oligonucleotides are adjacently hybridized to a template to form a ligation product, wherein the ligation is performed by a Chlorella Virus ligase (CV ligase), wherein the first oligonucleotide and/or second oligonucleotide is less than 8 nucleotides in length, wherein the first oligonucleotide hybridizes to a region on the template adjacent to the proximal terminus of the second oligonucleotide, and wherein the first oligonucleotide is fluorescently labeled, wherein the first oligonucleotide comprises a proximal portion that is (i) perfectly hybridized to the template and is (ii) L nucleotides long, wherein the first oligonucleotide's L+1th nucleotide is mismatched with the template; and

b. detecting the fluorescent label of the first oligonucleotide that has ligated to the second oligonucleotide.

2. The method of claim 1 , wherein the effiency of the ligation is at least 80%.

3. The method of claim 1 , wherein the proximal terminus of the first oligonucleotide is its 3′ terminus and the proximal terminus of the second oligonucleotide is its 5′terminus.

4. The method of claim 1 , wherein the proximal terminus of the first oligonucleotide is its 5′ terminus and the proximal terminus of the second oligonucleotide is its 3′terminus.

5. The method of claim 1 , wherein the second oligonucleotide and/or template is fluorescently labeled.

6. A method of claim 1 , wherein at least one of the first oligonucleotide, the template, and/or the second oligonucleotide is immobilized.

7. The method of claim 1 , wherein ligation is performed in the presence of a multiplicity of additional oligonucleotides that are at least partially complementary to the same region on the templae as the first oligonucleotide.

8. The method of claim 7 , wherein at least one of the multiplicity of additional oligonucleotides is labeled distinguishably from the first oligonucleotide.

9. The method of claim 7 , wherein the portion of the second oligonucleotide that is hybridized to the template is 2 to 20 nucleotides in length.

10. The method of claim 1 , wherein the ligation is repeated at least once.

11. The method of claim 10 , any ligation product of a previous ligation reaction is used as the second oligonucleotide of a next ligation.

12. The method of claim 10 , further comprising detecting whether the first oligonucleotide has ligated to the second oligonucleotide before repeating the ligation.

13. The method of claim 10 , wherein any ligation product of the previous ligation reaction is used as the template of the next ligation reaction.

14. The method of claim 1 , wherein the method comprises a ligase chain reaction.

15. The method of claim 1 , wherein the first oligonucleotide serces a probe function.

16. The method of claim 1 , wherein the second oligonucleotide serves a primer function.

17. The method of claim 1 , wherein the second oligonucleotide is extendable at its 3′ terminus.

18. A method of template-dependent ligation, said method comprising:

a. enzymatically ligating a first oligonucleotide and a second oligonucleotide, wherein said first oligonucleotide and said second oligonucleotide are hybridized to an RNA template, to form a ligation product, wherein the ligation is performed by a Chlorella Virus ligase (CV ligase), wherein the portion of the first oligonucleotide that is hybridized to the RNA template is 2 to 8 nucleotides in length and the portion of the second oligonucleotide that is hybridized to the RNA template is 2 to 20 nucleotides in length, wherein the first oligonucleotide is at least partially complementary to a region on the RNA template adjacent to the proximal terminus of the second oligonucleotide, and wherein the first oligonucleotide is labeled;

b. amplifying the ligation product; and

c. detecting the label of the amplified ligation product.

19. The method of claim 18 , wherein the efficiency of the ligation is atleast 80%.

20. The method of claim 18 , wherein the label is a fluorescent label.

21. The method of claim 18 , wherein the RNA template is an miRNA template.

22. The method of claim 18 , wherein the amplifying is performed by a polymerase chain reaction (PCR).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2015
From: KING, DAVID
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 035859/0968 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2013
From: HENDRICKS, STEPHEN
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 031181/0555 →
Continuity (5)
Provisional Application 61433502 · Jan 17, 2011
Provisional Application 61433488 · Jan 17, 2011
Provisional Application 61474205 · Apr 11, 2011
Provisional Application 61474168 · Apr 11, 2011
Related Publication 20140378315A1 · Dec 25, 2014
Cited By (1)
US 12,742,210